NF-kB inhibitor IT-901 shows promise in Richter syndromeJuly 5, 2017Leukemia, Myelodysplasia, Transplantation
Telomere length predicts FCR response in CLL patientsJuly 5, 2017Leukemia, Myelodysplasia, Transplantation
T receptor diversity may predict BCP-ALL response to blinatumomabJune 26, 2017Leukemia, Myelodysplasia, Transplantation
Gilteritinib shows safety, efficacy in relapsed/refractory AMLJune 24, 2017Leukemia, Myelodysplasia, Transplantation
Infections may trigger leukemia in the genetically susceptibleJune 23, 2017Leukemia, Myelodysplasia, TransplantationPediatrics
Optimizing therapy in relapsed CLL: ibrutinib and beyondJune 23, 2017Leukemia, Myelodysplasia, Transplantation
Patch is early indicator of temperature rise after HSCTJune 23, 2017Leukemia, Myelodysplasia, Transplantation
Antibody from AML survivor may prove therapeuticJune 23, 2017Leukemia, Myelodysplasia, Transplantation
FDA approves rituximab + hyaluronidase human for FL, DLBCL, and CLLJune 22, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersFollicular Lymphoma
Lenalidomide consolidation linked to extended overall survival in non-del(11q) CLLJune 22, 2017Leukemia, Myelodysplasia, Transplantation
Sequential triple therapy produces high response rates in CLLJune 21, 2017Leukemia, Myelodysplasia, Transplantation
iFCG achieves high MRD-negative remission in untreated CLLMay 30, 2017Leukemia, Myelodysplasia, Transplantation
In good-candidate CLL, don’t wait too long for alloHCTMay 22, 2017Leukemia, Myelodysplasia, Transplantation
Ibrutinib response in CLL/SLL less affected by select risk factorsMay 21, 2017Leukemia, Myelodysplasia, Transplantation
